Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,688,674
+$212,241 QoQ
Shares Held
22,399
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#1,524
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tyche Wealth Partners LLC holds $18,163,637 across 7 Drug Manufacturers - General names. JNJ ranks #1 (31.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
22,399 | $5,688,674 | |
| 2 | LLY |
ELI LILLY & Co
|
4,653 | $5,580,948 | |
| 3 | ABBV |
AbbVie Inc.
|
17,400 | $4,378,536 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,583 | $1,102,915 | |
| 5 | AMGN |
Amgen Inc
|
1,495 | $541,369 | |
| 6 | PFE |
Pfizer Inc
|
21,503 | $517,792 | |
| 7 | NVS |
Novartis AG
|
2,255 | $353,403 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,688,674 | 22,399 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,476,433 | 22,404 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,635,266 | 22,398 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $4,213,298 | 22,723 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,504,696 | 22,944 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,892,928 | 23,474 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,449,910 | 23,855 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $4,319,547 | 26,654 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $4,069,386 | 27,842 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $5,084,226 | 32,140 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $5,763,956 | 36,774 | Shares | Sole | 2024-01-30 | |
| No filing history on record for this holder in this stock. | ||||||